Orchestra BioMed has announced that the FDA has granted Breakthrough Device Designation for its atrioventricular interval modulation (AVIM) therapy, aimed at treating over 7.7 million U.S. patients ...
FDA has granted breakthrough device designation (BDD) for Orchestra BioMed's atrioventricular interval modulation (AVIM) therapy. Specifically, the designation is for an implantable device designed to ...
Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. The device is an atrio-ventricular interval modulation therapy, meaning it uses a ...
The Eurythmics’ “Sweet Dreams” is one of the most instantly recognizable songs on the pop charts. Whether it’s that iconic synth beat or Annie Lennox’s vocals, there’s just something about that song ...
As Qualcomm CEO Cristiano Amon describesa shift from smartphone-centric computing toward agent-centric experiences across devices, two Orchestra demonstrations show Conductor sEMG wristband enabling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results